ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 139 filers reported holding ACHILLION PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $509,000 | +48.4% | 84,506 | -11.4% | 0.00% | – |
| Q3 2019 | $343,000 | +60.3% | 95,401 | +19.6% | 0.00% | – |
| Q2 2019 | $214,000 | -28.2% | 79,780 | -20.7% | 0.00% | – |
| Q1 2019 | $298,000 | +96.1% | 100,546 | +4.8% | 0.00% | – |
| Q4 2018 | $152,000 | -59.2% | 95,965 | -5.4% | 0.00% | – |
| Q3 2018 | $373,000 | +10.7% | 101,444 | -14.8% | 0.00% | – |
| Q2 2018 | $337,000 | -22.5% | 119,111 | +1.7% | 0.00% | – |
| Q1 2018 | $435,000 | +15.1% | 117,142 | -10.7% | 0.00% | – |
| Q4 2017 | $378,000 | -57.1% | 131,194 | -33.2% | 0.00% | – |
| Q3 2017 | $882,000 | -12.6% | 196,538 | -10.5% | 0.00% | – |
| Q2 2017 | $1,009,000 | +11.1% | 219,647 | +1.8% | 0.00% | – |
| Q1 2017 | $908,000 | +13.9% | 215,820 | +11.9% | 0.00% | – |
| Q4 2016 | $797,000 | -33.8% | 192,889 | +29.7% | 0.00% | – |
| Q3 2016 | $1,204,000 | -5.9% | 148,680 | -9.3% | 0.00% | – |
| Q2 2016 | $1,280,000 | -9.8% | 164,014 | -10.8% | 0.00% | -100.0% |
| Q1 2016 | $1,419,000 | -44.0% | 183,795 | -21.7% | 0.00% | 0.0% |
| Q4 2015 | $2,534,000 | +46.9% | 234,849 | -6.0% | 0.00% | 0.0% |
| Q3 2015 | $1,725,000 | -31.8% | 249,730 | -12.5% | 0.00% | 0.0% |
| Q2 2015 | $2,529,000 | -95.5% | 285,394 | -95.0% | 0.00% | -90.9% |
| Q1 2015 | $56,004,000 | +1268.3% | 5,679,880 | +1599.8% | 0.01% | +450.0% |
| Q4 2014 | $4,093,000 | +52.2% | 334,144 | +23.9% | 0.00% | +100.0% |
| Q3 2014 | $2,690,000 | +37.9% | 269,603 | +4.6% | 0.00% | 0.0% |
| Q2 2014 | $1,951,000 | +147.9% | 257,812 | +7.7% | 0.00% | – |
| Q1 2014 | $787,000 | +1474.0% | 239,349 | +1493.9% | 0.00% | – |
| Q4 2013 | $50,000 | -98.9% | 15,017 | -99.0% | 0.00% | -100.0% |
| Q3 2013 | $4,681,000 | -76.1% | 1,549,986 | -35.2% | 0.00% | -80.0% |
| Q2 2013 | $19,576,000 | – | 2,393,137 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |